ChromaDex announced yesterday that it has entered into a stock purchase agreement for the sale of up to $25 million of its common stock to Horizons Ventures an entity owned by Mr. Li Ka-shing.
One can only speculate what triggered the move by Mr. Li Ka-shing, who is 89 years old. I would not be surprised if it is for the same reason as I purchased equity as well (see second paragraph, noticing positive effects of Niagen). But with Mr. Li Ka-shing owning retail brands in Europe such as Superdrug (UK), Marionnaud (France), Kruidvat (Benelux countries), and in Asia health and beauty retailer Watson’s store, PARKnSHOP supermarkets (and spin-off brands) it would seem that this also is a business driven investment and as Chromadex stated themselves: Niagen (nicotinamide riboside) is ready for the world.
With Chromadex cash position now dramatically improved and that combined with the networking clout of Horizon Ventures it is fair to expect that Nicotinamide Riboside will receive more attention and attract more research. In a wider context it would seem that anti-aging is gaining credibility, so good news all around.